The European Medicines Agency approved a drug change related to a Lupin facility in New Jersey, while market movements saw Infosys and Bajaj Finance fluctuate, and Thermax was listed among capital goods losers.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The European Medicines Agency approved a drug change related to a Lupin facility in New Jersey, while market movements saw Infosys and Bajaj Finance fluctuate, and Thermax was listed among capital goods losers.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
-
Infosys
Indian multinational technology company
- A market sell-off is underway, causing steep declines in the shares of major IT service providers including Infosys, Wipro, HCL, Larsen & Toubro, and Bharti Airtel.
- On September 28, 2026, the market experienced a crash: Infosys was the only Sensex stock to close higher, while Larsen & Toubro was the biggest loser.
-
Bajaj Finance
Indian non-banking financial company